239 related articles for article (PubMed ID: 26285574)
1. Re-evaluation of diagnostic parameters is crucial for obtaining accurate data on idiopathic pulmonary fibrosis.
Kaunisto J; Kelloniemi K; Sutinen E; Hodgson U; Piilonen A; Kaarteenaho R; Mäkitaro R; Purokivi M; Lappi-Blanco E; Saarelainen S; Kankaanranta H; Mursu A; Kanervisto M; Salomaa ER; Myllärniemi M
BMC Pulm Med; 2015 Aug; 15():92. PubMed ID: 26285574
[TBL] [Abstract][Full Text] [Related]
2. [Interstitial lung diseases among patients hospitalized in the Department of Respiratory Medicine in Radom District Hospital during the years 2000-2009].
Szafrański W
Pneumonol Alergol Pol; 2012; 80(6):523-32. PubMed ID: 23109204
[TBL] [Abstract][Full Text] [Related]
3. EMPIRE Registry, Czech Part: Impact of demographics, pulmonary function and HRCT on survival and clinical course in idiopathic pulmonary fibrosis.
Doubková M; Švancara J; Svoboda M; Šterclová M; Bartoš V; Plačková M; Lacina L; Žurková M; Binková I; Bittenglová R; Lošťáková V; Merta Z; Šišková L; Tyl R; Lisá P; Šuldová H; Petřík F; Pšikalová J; Řihák V; Snížek T; Reiterer P; Homolka J; Musilová P; Lněnička J; Palúch P; Hrdina R; Králová R; Hortvíková H; Strenková J; Vašáková M
Clin Respir J; 2018 Apr; 12(4):1526-1535. PubMed ID: 28862397
[TBL] [Abstract][Full Text] [Related]
4. Incidence of idiopathic pulmonary fibrosis in Korea based on the 2011 ATS/ERS/JRS/ALAT statement.
Gjonbrataj J; Choi WI; Bahn YE; Rho BH; Lee JJ; Lee CW
Int J Tuberc Lung Dis; 2015 Jun; 19(6):742-6. PubMed ID: 25946370
[TBL] [Abstract][Full Text] [Related]
5. A cohort study of interstitial lung diseases in central Denmark.
Hyldgaard C; Hilberg O; Muller A; Bendstrup E
Respir Med; 2014 May; 108(5):793-9. PubMed ID: 24636811
[TBL] [Abstract][Full Text] [Related]
6. Change in forced vital capacity and associated subsequent outcomes in patients with newly diagnosed idiopathic pulmonary fibrosis.
Reichmann WM; Yu YF; Macaulay D; Wu EQ; Nathan SD
BMC Pulm Med; 2015 Dec; 15():167. PubMed ID: 26714746
[TBL] [Abstract][Full Text] [Related]
7. [Characteristics and management of idiopathic pulmonary fibrosis: INSIGHTS-IPF registry].
Behr J; Hoeper MM; Kreuter M; Klotsche J; Wirtz H; Pittrow D
Dtsch Med Wochenschr; 2012 Dec; 137(49):2586-8. PubMed ID: 23188642
[TBL] [Abstract][Full Text] [Related]
8. Comparisons of Prognosis between Surgically and Clinically Diagnosed Idiopathic Pulmonary Fibrosis Using Gap Model: A Korean National Cohort Study.
Lee SH; Kim SY; Kim DS; Kim YW; Chung MP; Uh ST; Park CS; Jeong SH; Park YB; Lee HL; Shin JW; Lee EJ; Lee JH; Jegal Y; Lee HK; Kim YH; Song JW; Park MS
Medicine (Baltimore); 2016 Mar; 95(11):e3105. PubMed ID: 26986154
[TBL] [Abstract][Full Text] [Related]
9. Underlying and immediate causes of death in patients with idiopathic pulmonary fibrosis.
Kärkkäinen M; Nurmi H; Kettunen HP; Selander T; Purokivi M; Kaarteenaho R
BMC Pulm Med; 2018 May; 18(1):69. PubMed ID: 29751748
[TBL] [Abstract][Full Text] [Related]
10. Demographic and clinical profile of idiopathic pulmonary fibrosis patients in Spain: the SEPAR National Registry.
Fernández-Fabrellas E; Molina-Molina M; Soriano JB; Portal JAR; Ancochea J; Valenzuela C; Xaubet A;
Respir Res; 2019 Jun; 20(1):127. PubMed ID: 31208406
[TBL] [Abstract][Full Text] [Related]
11. The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis.
Guenther A; Krauss E; Tello S; Wagner J; Paul B; Kuhn S; Maurer O; Heinemann S; Costabel U; Barbero MAN; Müller V; Bonniaud P; Vancheri C; Wells A; Vasakova M; Pesci A; Sofia M; Klepetko W; Seeger W; Drakopanagiotakis F; Crestani B
Respir Res; 2018 Jul; 19(1):141. PubMed ID: 30055613
[TBL] [Abstract][Full Text] [Related]
12. Idiopathic Pulmonary Fibrosis in United States Automated Claims. Incidence, Prevalence, and Algorithm Validation.
Esposito DB; Lanes S; Donneyong M; Holick CN; Lasky JA; Lederer D; Nathan SD; O'Quinn S; Parker J; Tran TN
Am J Respir Crit Care Med; 2015 Nov; 192(10):1200-7. PubMed ID: 26241562
[TBL] [Abstract][Full Text] [Related]
13. Idiopathic Pulmonary Fibrosis (IPF) incidence and prevalence in Italy.
Agabiti N; Porretta MA; Bauleo L; Coppola A; Sergiacomi G; Fusco A; Cavalli F; Zappa MC; Vignarola R; Carlone S; Facchini G; Mariotta S; Palange P; Valente S; Pasciuto G; Pezzuto G; Orlandi A; Fusco D; Davoli M; Saltini C; Puxeddu E
Sarcoidosis Vasc Diffuse Lung Dis; 2014 Oct; 31(3):191-7. PubMed ID: 25363218
[TBL] [Abstract][Full Text] [Related]
14. Australian Idiopathic Pulmonary Fibrosis Registry: vital lessons from a national prospective collaborative project.
Moodley Y; Goh N; Glaspole I; Macansh S; Walters EH; Chapman S; Hopkins P; Reynolds PN; Zappala C; Cooper W; Mahar A; Ellis S; McCormack S; Darbishire W; Wood-Baker R; Corte TJ;
Respirology; 2014 Oct; 19(7):1088-91. PubMed ID: 25123691
[TBL] [Abstract][Full Text] [Related]
15. Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a population-based study.
Fernández Pérez ER; Daniels CE; Schroeder DR; St Sauver J; Hartman TE; Bartholmai BJ; Yi ES; Ryu JH
Chest; 2010 Jan; 137(1):129-37. PubMed ID: 19749005
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of lung cancer in idiopathic pulmonary fibrosis with single lung transplant versus non-transplanted patients: a retrospective observational study.
Gershman E; Zer A; Pertzov B; Shtraichman O; Shitenberg D; Heching M; Rosengarten D; Kramer M
BMJ Open Respir Res; 2020 Jun; 7(1):. PubMed ID: 32565443
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of lung cancer among patients with idiopathic pulmonary fibrosis and interstitial lung disease - analysis of institutional and population data.
Yoon JH; Nouraie M; Chen X; Zou RH; Sellares J; Veraldi KL; Chiarchiaro J; Lindell K; Wilson DO; Kaminski N; Burns T; Trejo Bittar H; Yousem S; Gibson K; Kass DJ
Respir Res; 2018 Oct; 19(1):195. PubMed ID: 30285867
[TBL] [Abstract][Full Text] [Related]
18. Association of early suspected acute exacerbations of idiopathic pulmonary fibrosis with subsequent clinical outcomes and healthcare resource utilization.
Yu YF; Macaulay DS; Reichmann WM; Wu EQ; Nathan SD
Respir Med; 2015 Dec; 109(12):1582-8. PubMed ID: 26607877
[TBL] [Abstract][Full Text] [Related]
19. Hospital-Based Resource Use and Costs Among Patients With Idiopathic Pulmonary Fibrosis Enrolled in the Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry.
Fan Y; Bender SD; Conoscenti CS; Davidson-Ray L; Cowper PA; Palmer SM; de Andrade JA;
Chest; 2020 Jun; 157(6):1522-1530. PubMed ID: 32004554
[TBL] [Abstract][Full Text] [Related]
20. The clinical course of idiopathic pulmonary fibrosis and its association to quality of life over time: longitudinal data from the INSIGHTS-IPF registry.
Kreuter M; Swigris J; Pittrow D; Geier S; Klotsche J; Prasse A; Wirtz H; Koschel D; Andreas S; Claussen M; Grohé C; Wilkens H; Hagmeyer L; Skowasch D; Meyer JF; Kirschner J; Gläser S; Kahn N; Welte T; Neurohr C; Schwaiblmair M; Held M; Bahmer T; Oqueka T; Frankenberger M; Behr J
Respir Res; 2019 Mar; 20(1):59. PubMed ID: 30876420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]